<oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:title>Efficacy of Combination Therapy with Intravenous Ketorolac and Metoclopramide for Pediatric Migraine Therapy in the Emergency Department</dc:title><dc:identifier>https://doi.org/10.7939/DVN/10959</dc:identifier><dc:creator>Richer, Lawrence</dc:creator><dc:publisher>UAL Dataverse</dc:publisher><dc:description>The purpose of this study is to investigate whether the combination of ketorolac (an anti-inflammatory pain medication) and metoclopramide (an anti-nauseant that may also relieve migraine headaches) is better than metoclopramide by itself when treating children in the Emergency Department.</dc:description><dc:subject>Medicine, Health and Life Sciences</dc:subject><dc:subject>emergency departments</dc:subject><dc:subject>pediatrics</dc:subject><dc:subject>metoclopramide</dc:subject><dc:subject>ketorolac</dc:subject><dc:subject>intravenous injections</dc:subject><dc:subject>emergencies</dc:subject><dc:subject>randomized controlled trial</dc:subject><dc:subject>migraine disorders</dc:subject><dc:subject>headache disorders</dc:subject><dc:date>2012</dc:date><dc:type>Interview data; Clinical data</dc:type><dc:source>Visual Analogue Scale (VAS); Faces Pain Scale - Revised (FPS-R)</dc:source></oai_dc:dc>